他汀类药物在缺血性脑血管病二级预防中的应用效果及其影响因素

doi:10.3969/j.issn.1671-7171.2024.07.029

Abstract
Figure/Table
References
Related Citation (15)

Download: PDF (1210 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To explore the application effect and influencing factors of statins in the secondary prevention of ischemic cerebrovascular disease (ICVD).【Methods】A total of 109 ICVD patients treated in our hospital were followed up for one year. One patient died, and two were lost to follow-up. Patients were divided into a recurrence group and a non-recurrence group based on whether ICVD recurred. Univariate analysis was used to compare the clinical data of the two groups and to explore the factors affecting the preventive effect of statins. 【Results】Among the 106 patients, 15 cases (14.15%) had ICVD recurrence, while 91 cases (85.85%) did not have recurrence of ICVD. There were no statistically significant differences in age, gender, family history, smoking history, alcohol consumption history, white blood cell count, and blood glucose levels between the recurrence and non-recurrence groups (P>0.05). However, significant differences were found in body mass index (BMI), educational level, medical payment method, number of comorbidities, types of medications taken, and compliance (P<0.05). Multivariate regression analysis showed that high BMI, low educational level, self-payment for medical expenses, a high number of comorbidities, taking multiple types of medications, and low compliance were independent risk factors for recurrence in the secondary prevention of ICVD with statins (P<0.05). 【Conclusion】 The effect of statins in the secondary prevention of ICVD is influenced by factors such as patients' BMI, educational level, medical payment method, comorbidities, types of medications, and compliance. Optimizing secondary prevention requires attention to these related factors.

Key words： Brain Ischemia Hydroxymethylglutaryl-CoA Reductase Inhibitors/TU Root Cause Analysis

Received: 20 January 2024

PACS:

R743

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	MENG Tingting
	GENG Desheng

Cite this article:

MENG Tingting,GENG Desheng. Application Effect and Influencing Factors of Statins in Secondary Prevention of Ischemic Cerebrovascular Disease[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(7): 1061-1063.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.07.029 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I7/1061

[1] 刘丽萍,陈玮琪,段婉莹,等.中国脑血管病临床管理指南(节选版)——缺血性脑血管病临床管理[J].中国卒中杂志,2019,14(7):85-102.
[2] 陈梅,郭明升,刘娟,等.脑梗死二级预防患者阿托伐他汀依从性降低的危险因素分析[J].河北医科大学学报,2019,40(2):149-152.
[3] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国缺血性卒中和短暂性脑缺血发作二级预防指南2022[J].中华神经科杂志,2022,55(10):40.
[4] 张凌锋.他汀类药物对复发缓解型多发性硬化患者缓解期认知功能影响的系统评价[J].中国医学创新,2019,16(23):22-26.
[5] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国各类主要脑血管病诊断要点2019[J].中华神经科杂志,2019,52(9):710-715.
[6] 俞吉,冉烁,徐玲.Morisky用药依从性量表8条目在老年慢性病患者用药评价中的应用[J].临床药物治疗杂志,2020,18(11):63-66.
[7] 郭强蕊,张士奇,毛泽宇,等.银杏叶提取物联合阿司匹林对经CT检测诊断为脑栓塞引起的老年缺血性脑血管病的临床疗效[J].中国老年学杂志,2023,43(14):3347-3350.
[8] 姚宜琪,袁梦莹,何霞,等.他汀类药物在缺血性卒中二级预防中的作用机制及应用现状[J].中国临床药理学杂志,2023,39(17):2556-2560.
[9] 张长青,李子孝,王春娟,等.他汀类药物服用持续性对缺血性卒中患者复发的影响[J].中国卒中杂志,2022,17(2):122-127.
[10] 缪兴红,姜建芳,江英.南通地区缺血性卒中二级预防药物应用现状及依从性随访分析[J].中国医学创新,2020,17(27):156-160.
[11] 程丝,胥芹,许喆,等.既往卒中病史对缺血性脑血管病患者卒中结局的影响研究[J].中国卒中杂志,2021,16(12):1242-1247.
[12] 朱慧颖,余萍,梅俊华,等.急性脑梗死患者脑微出血的危险因素及其对心脑血管事件发生率影响的研究[J].中国现代医学杂志,2019,29(3):88-92.
[13] 马悦霞,冯俊艳,孙淑华,等.缺血性脑血管病出院患者用药依从性现状及影响因素研究[J].河北医科大学学报,2022,43(1):16-21.

[1]	. [J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(8): 1222-1224.